Article Text

Download PDFPDF

Greetings from the editor 2020
Free
  1. Josef S Smolen
  1. Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria
  1. Correspondence to Dr Josef S Smolen, Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria; josef.smolen{at}meduniwien.ac.at

Statistics from Altmetric.com

A new decade of the 21st century is starting. We have experienced multiple shake-ups in the course of the last decade, the ‘teens-decade’—political ones and social ones, such as the climate crisis which affects us globally and might even influence the epidemiology of rheumatic diseases in the not too distant future. Hopefully the new decade will find solutions for some of the burning problems of the planet and its societies.

In rheumatology, the first decade of this millennium brought novel therapies especially for rheumatoid arthritis (RA),1 2 changing the lives of millions of patients with RA around the world and making rheumatology one of the most successful medical specialties, attracting many young people to specialise in the field. The second decade brought several major therapeutic advances beyond tumour necrosis factor inhibitors especially for patients with psoriatic arthritis and axial spondyloarthritis3 4; the advent of biosimilars …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.